Overall, IDH-mutant gliomas rely on lactate/pyruvate and glutamine/glutamate as anaplerotic substances to support TCA cycle activity, facilitate fatty acid metabolism, and increase 2-HG accumulation during MT. The gene discussed is IDH1; the disease is glioma.